SGLT2 INHIBITORS: A NEW CLASS OF DRUGS FOR TYPE-II DIABETES MELLITUS

Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 10

Abstract

Diabetes is on the rise. No longer a disease of predominantly rich nations, the prevalence of diabetes is steadily increasing everywhere, most markedly in the world’s middle-income countries. Sodium-glucose co-transporter-2 (SGLT2) inhibitors are a new group of oral medications used for treating type II Diabetes Mellitus. The drugs work by helping the kidneys to lower the blood glucose levels. Globally, an estimated 422 million adults were living with diabetes in 2014, compared to 108 million in 1980. The global prevalence of diabetes has nearly doubled since 1980, rising from 4.7% to 8.5% in the adult population. This reflects an increase in associated risk factors such as being overweight or obese. Over the past decade, diabetes prevalence has risen faster in low- and middle-income countries than in high-income countries. The present therapeutic classes of anti-diabetic drugs are not adequately effective in maintaining long-term glycemic control in the most patients. Sodium glucose transporter-2 (SGLT2) inhibitors including Dapagliflozin, Canagliflozin and Empagliflozin act by a novel insulin-independent mechanism by blocking glucose reabsorption in the proximal convoluted tubule resulting in markedly increased glycosuria, and blocking the formation of proteins.

Authors and Affiliations

Lahari Samudrala

Keywords

Related Articles

ACUTE AND SUB-ACUTE TOXICITY STUDIES OF AQUEOUS DECOCTION OF THE TRUNK BARKS FROM LANNEA MICROCARPA ENGL. AND K. KRAUSE (ANACARDIACEAE) IN RODENTS

Lannea microcarpa Engl. & K. Krause (Anacardiaceae) is a multipurpose plant mostly distributed in various tropical African countries, including Burkina Faso and commonly known as African grape in French. To ensure safe u...

AN INNOVATIVE APPROACH OF SPECIAL LAYERED TABLET TECHNOLOGY

Aims: The aim of this research was to describe multiple layered tablet dosage form and their advantages, as well as recent developments in the field of layered tablets, as well as local & globally marketed layer tabled w...

AUTECOLOGY AND INSECTICIDAL POTENTIAL OF MENTHA LONGIFOLIA FROM MADINAH EL MONAWARA

Mentha plants are grown in abundance in Al-Madina. Their potentials in the medicine and aromatic industry are widely studied. Soil physicochemical studies were carried out to determine the best condition for the growth o...

HERBAL REMEDIES TO TREAT ANXIETY DISORDERS

Anxiety, fear and worry are all completely natural human feelings. If these feelings occur and endure for an extended period, it affects both physical and mental health. This leads to clinical anxiety disorders. Anxiety...

DEVELOPMENT AND VALIDATION OF STABILITY-INDICATING RP-HPLC METHOD FOR SIMULTANEOUS ESTIMATION OF ROSUVASTATIN AND GLIBENCLAMIDE

A convenient and rapid reverse phase-HPLC (RP-HPLC) method has been developed and validated for simultaneous estimation of rosuvastatin (RSV) and glibenclamide (GBC) according to international conference on harmonization...

Download PDF file
  • EP ID EP618988
  • DOI -
  • Views 153
  • Downloads 0

How To Cite

Lahari Samudrala (2017). SGLT2 INHIBITORS: A NEW CLASS OF DRUGS FOR TYPE-II DIABETES MELLITUS. WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE, 6(10), 233-247. https://europub.co.uk/articles/-A-618988